A Safety and Pharmakokinetic Study of A4250 Alone or in Combination With A3384
Status:
Completed
Trial end date:
2014-05-01
Target enrollment:
Participant gender:
Summary
The primary objectives of the study are to evaluate the safety, tolerability and
pharmacokinetics of A4250 after single or multiple oral doses in healthy subjects. In
addition, will evaluate A4250 in combination with cholestyramine.